Austrian lawmakers are close to banning the use of Roundup in that country, after Parliament voted to approve legislation removing it from the market there. The bill, spurred by glyphosate cancer concerns, must still be approved by the upper chamber and the nation’s president.…
European regulators have placed new restrictions on the use of Xeljanz while they continue to review potential pulmonary embolism risks.…
Bayer has released all of the studies on glyphosate used by European regulators to declare that the weed killer is safe.…
Pfizer is suing Ajanta Pharma over plans to release a generic version of Xeljanz years before its patent protection is scheduled to run out.…
Xeljanz side effects can cause pulmonary embolism at high doses, European drug regulators warn.…
An EU court has ordered the release of study documents which European regulators, accused of being too cozy with Monsanto, used to determine that Roundup exposure did not cause cancer.…
European regulators are raising concerns that the uterine fibroid drug Esmya, awaiting approval in the U.S., may be linked to liver damage and liver failure risks.…
A 5-year license renewal for Roundup and it’s active ingredient, glyphosate, passed in the European Union on Monday by a narrow margin after Germany changed its vote from abstention.…
France will oppose a five-year license renewal for Roundup and other glyphosate products in Europe, expected to be proposed today by the European Commission.…
The European Commission again failed to garner enough votes to renew the license for Roundup and other glyphosate weed killers, bringing the European Union closer to a ban.…
